• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

同一患者体内的甲状腺髓样癌和乳头状甲状腺癌作为碰撞瘤并存

Medullary Thyroid Carcinoma and Papillary Thyroid Carcinoma in the Same Patient as a Collision Tumour.

作者信息

Dikbas Oguz, Duman Aslihan Alpaslan, Guvendi Gulname Findik

机构信息

Giresun University School of Medicine, Department of Internal Medicine, Turkey.

Giresun University School of Medicine, Department of Pathology, Turkey.

出版信息

Case Rep Endocrinol. 2019 Mar 12;2019:4038628. doi: 10.1155/2019/4038628. eCollection 2019.

DOI:10.1155/2019/4038628
PMID:30993022
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6434312/
Abstract

AIM

Papillary thyroid carcinoma (PTC) and medullary thyroid carcinoma (MTC) are two different types of thyroid carcinoma with significant different clinical and histological findings. Their coexistence in the same patient is a very rare event which demands different clinical approach.

CASE REPORT

We report a case with concurrent MTC and PTC in the same thyroid having characteristics of a collision tumour. A 35-year-old patient has admitted to endocrinology outpatient department with complaint of pain in the neck. Physical examination revealed 2 cm nodule on the thyroid right lobe. Serum thyroid hormone levels were within normal range. Ultrasonography revealed a 23x15 mm hypoechoic nodule with micro calcifications and cystic areas on the right lobe. Preoperative serum calcitonin was 2 pg/ml (0-11.5). PTK 1.7 cm and MTK 1.8 cm in the same thyroid with healthy tissue in between them were detected on pathological examination. RET gene mutation was negative. She has been followed up to now without any evidence of disease.

CONCLUSION

This is a collision tumour since lesions with features of MTC and PTC were detected in two different locations and separated by normal thyroid tissue. Germline point mutation of the RET gene had a potential role in the development of both MTC and PTC. On the other side, familial concurrent MTC and PTC without RET gene mutation was also published. Both RET and BRAF genes had a role in the development of the medullary and papillary collision tumours. We do not know the presence of BRAF gene mutation in this case report yet.

摘要

目的

甲状腺乳头状癌(PTC)和甲状腺髓样癌(MTC)是两种不同类型的甲状腺癌,具有显著不同的临床和组织学表现。它们在同一患者中共存是非常罕见的情况,需要不同的临床处理方法。

病例报告

我们报告一例同一甲状腺内同时存在MTC和PTC的病例,具有碰撞瘤的特征。一名35岁患者因颈部疼痛就诊于内分泌门诊。体格检查发现甲状腺右叶有一个2厘米的结节。血清甲状腺激素水平在正常范围内。超声检查显示右叶有一个23×15毫米的低回声结节,伴有微钙化和囊性区域。术前血清降钙素为2皮克/毫升(0 - 11.5)。病理检查在同一甲状腺内检测到PTC为1.7厘米,MTC为1.8厘米,两者之间有健康组织。RET基因突变阴性。到目前为止,她一直在接受随访,没有任何疾病迹象。

结论

这是一个碰撞瘤,因为在两个不同位置检测到具有MTC和PTC特征的病变,且被正常甲状腺组织分隔。RET基因的种系点突变在MTC和PTC的发生中可能起作用。另一方面,也有关于无RET基因突变的家族性MTC和PTC并存的报道。RET和BRAF基因在髓样和乳头状碰撞瘤的发生中都起作用。在本病例报告中,我们尚不知道BRAF基因突变的情况。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/960f/6434312/24c2c4aa068d/CRIE2019-4038628.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/960f/6434312/a0d3e99950ac/CRIE2019-4038628.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/960f/6434312/26fa9827ea30/CRIE2019-4038628.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/960f/6434312/168dec07ec94/CRIE2019-4038628.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/960f/6434312/24c2c4aa068d/CRIE2019-4038628.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/960f/6434312/a0d3e99950ac/CRIE2019-4038628.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/960f/6434312/26fa9827ea30/CRIE2019-4038628.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/960f/6434312/168dec07ec94/CRIE2019-4038628.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/960f/6434312/24c2c4aa068d/CRIE2019-4038628.004.jpg

相似文献

1
Medullary Thyroid Carcinoma and Papillary Thyroid Carcinoma in the Same Patient as a Collision Tumour.同一患者体内的甲状腺髓样癌和乳头状甲状腺癌作为碰撞瘤并存
Case Rep Endocrinol. 2019 Mar 12;2019:4038628. doi: 10.1155/2019/4038628. eCollection 2019.
2
Intermixed medullary and papillary thyroid cancer in a patient with renal cell carcinoma.一名肾细胞癌患者合并有髓样和乳头状甲状腺癌。
Endocrinol Diabetes Metab Case Rep. 2020 Jun 4;2020. doi: 10.1530/EDM-20-0025.
3
Classical point mutations of RET, BRAF and RAS oncogenes are not shared in papillary and medullary thyroid cancer occurring simultaneously in the same gland.RET、BRAF和RAS癌基因的经典点突变在同一腺体中同时发生的甲状腺乳头状癌和甲状腺髓样癌中并不相同。
J Endocrinol Invest. 2017 Jan;40(1):55-62. doi: 10.1007/s40618-016-0526-5. Epub 2016 Aug 17.
4
Medullary and papillary carcinoma of the thyroid gland occurring as a collision tumour: report of three cases with molecular analysis and review of the literature.甲状腺髓样癌和乳头状癌作为碰撞瘤出现:三例报告及分子分析与文献复习
Endocr Relat Cancer. 2005 Jun;12(2):281-9. doi: 10.1677/erc.1.00901.
5
Papillary and Medullary Thyroid Carcinomas Presenting as Collision Tumors: A Case Series of 21 Cases at a Tertiary Care Cancer Center.甲状腺乳头和髓样癌作为碰撞瘤表现:一家三级癌症中心的 21 例病例系列。
Head Neck Pathol. 2021 Dec;15(4):1137-1146. doi: 10.1007/s12105-021-01323-7. Epub 2021 Apr 11.
6
A Malignant Duo: Mixed Medullary and Follicular Variant Papillary Thyroid Cancer.恶性组合:髓样与滤泡样变异型混合性甲状腺乳头状癌
Cureus. 2024 Aug 19;16(8):e67231. doi: 10.7759/cureus.67231. eCollection 2024 Aug.
7
Synchronous metastatic medullary and papillary thyroid carcinomas in a patient with germline RET mutation: case report, molecular analysis, and implications for pathogenesis.患者携带种系 RET 突变,同时患有髓样和乳头甲状腺癌:病例报告、分子分析及发病机制的影响
Endocr Pathol. 2010 Jun;21(2):115-9. doi: 10.1007/s12022-010-9117-8.
8
Synchronous occurrence of medullary and papillary carcinoma of the thyroid in a patient with cutaneous melanoma: determination of BRAFV600E in peripheral blood and tissues. Report of a case and review of the literature.皮肤黑色素瘤患者甲状腺髓样癌与乳头状癌的同步发生:外周血和组织中BRAFV600E的检测。1例病例报告及文献复习
Endocr Pathol. 2014 Sep;25(3):324-31. doi: 10.1007/s12022-014-9303-1.
9
Thirty synchronous medullary and papillary thyroid carcinomas.30 例同步性甲状腺髓样癌和乳头状癌。
Front Endocrinol (Lausanne). 2023 Mar 31;14:1153248. doi: 10.3389/fendo.2023.1153248. eCollection 2023.
10
Concurrent lymph node metastases of medullary and papillary thyroid carcinoma in a case with RET oncogene germline mutation.1例伴有RET原癌基因种系突变的甲状腺髓样癌和乳头状癌同时发生淋巴结转移
Endocr Pathol. 2003 Fall;14(3):269-76. doi: 10.1007/s12022-003-0020-4.

引用本文的文献

1
Case reports of collision and composite carcinomas of the thyroid: an insight into their origin and clinical significance.甲状腺碰撞性和复合性癌的病例报告:对其起源和临床意义的深入了解。
BMC Endocr Disord. 2023 Aug 14;23(1):173. doi: 10.1186/s12902-023-01409-z.
2
Clinicopathological features and prognostic factors analysis of multiple synchronous distinct subtypes of primary thyroid carcinoma.多灶性甲状腺原发癌不同亚型并存的临床病理特征及预后因素分析。
Endocrine. 2023 Mar;79(3):491-501. doi: 10.1007/s12020-022-03243-0. Epub 2022 Nov 18.
3
Synchronous Hürthle cell and medullary thyroid carcinomas.

本文引用的文献

1
Hereditary and familial thyroid tumours.遗传性和家族性甲状腺肿瘤。
Histopathology. 2018 Jan;72(1):70-81. doi: 10.1111/his.13373.
2
The thyroid cancer epidemic, 2017 perspective.2017年视角下的甲状腺癌流行情况
Curr Opin Endocrinol Diabetes Obes. 2017 Oct;24(5):332-336. doi: 10.1097/MED.0000000000000359.
3
Differentiated thyroid cancer in Iran - initial observations, histological features, management of the disease, and tumor recurrence: A review of 1689 cases.伊朗的分化型甲状腺癌——初步观察、组织学特征、疾病管理及肿瘤复发:1689例病例回顾
同步 Hurthle 细胞和髓样甲状腺癌。
BMJ Case Rep. 2022 May 31;15(5):e248879. doi: 10.1136/bcr-2022-248879.
4
Collision tumors of the thyroid. A special clinical and pathological entity.甲状腺碰撞瘤。一种特殊的临床和病理实体。
Arch Clin Cases. 2021 Dec 29;8(4):84-90. doi: 10.22551/2021.33.0804.10191. eCollection 2021.
5
Significance of chromogranin A and synaptophysin in medullary thyroid carcinoma.降钙素和突触素在甲状腺髓样癌中的意义。
Bosn J Basic Med Sci. 2021 Oct 1;21(5):535-541. doi: 10.17305/bjbms.2020.5407.
6
Medullary thyroid carcinoma combined with papillary thyroid carcinoma: case report and literature review.甲状腺髓样癌合并甲状腺乳头状癌:病例报告及文献复习
Int J Clin Exp Pathol. 2020 Oct 1;13(10):2710-2717. eCollection 2020.
Indian J Cancer. 2016 Apr-Jun;53(2):261-264. doi: 10.4103/0019-509X.197727.
4
Germline ESR2 mutation predisposes to medullary thyroid carcinoma and causes up-regulation of RET expression.种系ESR2突变易患甲状腺髓样癌并导致RET表达上调。
Hum Mol Genet. 2016 May 1;25(9):1836-45. doi: 10.1093/hmg/ddw057. Epub 2016 Mar 3.
5
Multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma: an update.多发性内分泌腺瘤病 2 型和家族性甲状腺髓样癌:更新。
J Clin Endocrinol Metab. 2013 Aug;98(8):3149-64. doi: 10.1210/jc.2013-1204. Epub 2013 Jun 6.
6
Worldwide increasing incidence of thyroid cancer: update on epidemiology and risk factors.全球甲状腺癌发病率不断上升:流行病学与风险因素的最新情况
J Cancer Epidemiol. 2013;2013:965212. doi: 10.1155/2013/965212. Epub 2013 May 7.
7
Overexpression of miR-10a and miR-375 and downregulation of YAP1 in medullary thyroid carcinoma.在甲状腺髓样癌中,miR-10a 和 miR-375 的过表达和 YAP1 的下调。
Exp Mol Pathol. 2013 Aug;95(1):62-7. doi: 10.1016/j.yexmp.2013.05.001. Epub 2013 May 16.
8
Molecular genetics of medullary thyroid carcinoma: the quest for novel therapeutic targets.甲状腺髓样癌的分子遗传学:寻找新的治疗靶点
J Mol Endocrinol. 2009 Oct;43(4):143-55. doi: 10.1677/JME-09-0024. Epub 2009 Apr 21.
9
Medullary thyroid cancer: therapeutic targets and molecular markers.甲状腺髓样癌:治疗靶点与分子标志物
Curr Opin Oncol. 2007 Jan;19(1):18-23. doi: 10.1097/CCO.0b013e32801173ea.
10
Increasing incidence of thyroid cancer in the United States, 1973-2002.1973年至2002年美国甲状腺癌发病率上升情况。
JAMA. 2006 May 10;295(18):2164-7. doi: 10.1001/jama.295.18.2164.